Volume 11, Number 6—June 2005
Research
Global Spread of Vancomycin-resistant Enterococcus faecium from Distinct Nosocomial Genetic Complex
Table 1
Epidemiologic source | Genetic and phenotypic features* |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Complex-17 |
Other† |
Complex-17 |
Other† |
Complex-17 |
Other† |
Complex-17‡ | Other†‡ | Log odds§ | |||||||
AmR | AmS | AmR | AmS | PAI+ | PAI– | PAI+ | PAI– | VanR | VanS | VanR | VanS | ||||
Animal surveillance (n = 96), % | 1 | 0 | 2 | 93 | 0 | 1 | 0 | 94 | 0 | 1 | 43 | 52 | 1 [1] | 95 [99] | –4.55 |
Community surveillance (n = 57), % | 0 | 0 | 1 | 46 | 3 | 0 | 0 | 47 | 3 | 0 | 17 | 37 | 3 [5] | 54 [95] | –2.89 |
Hospital surveillance (n = 64), % | 14 | 0 | 7 | 40 | 7 | 8 | 0 | 49 | 13 | 2 | 32 | 17 | 15 [23] | 49 [77] | –1.18 |
Clinical (n = 162), % | 85 | 2 | 13 | 47 | 47 | 47 | 4 | 57 | 21 | 73 | 22 | 45 | 95 [59] | 67 [51 | 0.35 |
Hospital outbreak (n = 32), % | 26 | 0 | 3 | 1 | 20 | 6 | 3 | 1 | 24 | 4 | 4 | 0 | 28 [88] | 4 [12] | 1.95 |
*Ampicillin resistant (AmR) or susceptible (AmS) not determined in 30 isolates, PAI present (PAI+) or absent (PA–) not determined in 17 isolates, vancomycin resistant (VanR) or susceptible (VanS) not determined in 1 isolate.
†Not belonging to complex-17.
‡Numbers in brackets refer to the percentage of isolates that belong to the complex.
§The natural logarithm of the proportion of samples from an epidemiologic source belonging to complex-17.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.